All posts in Biologics
BioRestorative Therapies Signs License Agreement for Stem Cell Disc/Spine Procedure
JUPITER, Fla., Jan. 31, 2012 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX) ("BRT") today announced that it has entered into a License Agreement with Regenerative Sciences, LLC ("RS") with respect to certain stem cell-related technology and clinical treatment procedures developed by RS. The ...
An Inteview with Paul Nichols
We recently spoke with Paul Nichols, the current Executive Chairman of Bio2 Technologies who formerly worked with HealthpointCapital as President and CEO of Nexa Orthopedics. Learn what he
Geron Selling Off Embryonic Stem Cell Technology
After nearly $450 million of equity raised and a record breaking $40 million FDA submission, Geron is throwing in the towel regarding its ground breaking embryonic stem cell
Pioneer® Surgical Technology, Inc. Announces the Expansion of its North Carolina Biomanufacturing Facility
Pioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility. The location houses the primary manufacturing operations for Pioneer Surgical’s
FDA approval of BioMimetic’s Augment Bone Graft dependent on more information
In a post-panel response letter, the FDA told BioMimetic Therapeutics Inc. that it would need to submit more information about the safety and efficacy of its Augment Bone
Judge grants Ex-Stryker Biotech exec’s request to sever charges in fraud case
MiMedx Group, Inc. Receives CE Certification for Its CollaFix™ Surgical Mesh CD
KENNESAW, Ga., Jan. 10, 2012 -- /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic
Cascade Medical Enterprises, LLC Announces the Sale of Their Orthopedic Business
WAYNE, N.J., Jan. 6, 2012 /PRNewswire via COMTEX/ -- Cascade Medical Enterprises, LLC (CME), a leading company with proprietary platelet-rich plasma (PRP) and platelet-rich fibrin matrix (PRFM)
Pioneer® Surgical Announces First Human Use of nanOss® Bioactive 3D
Pioneer Surgical today announces the first clinical use ofnanOss Bioactive 3D, a three-dimensionally shaped addition to its flagship biologic bone graft product line, nanOss
SNN spins out biologics unit in JV with Essex Woodlands
British orthopedic titan Smith & Nephew (NYSE:SNN) shuffled its business deck yet again with the spinout of its biologics and clinical
FDA seeks more info from BioMimetic
BioMimetic Therapeutics Inc. (Nasdaq: BMTI) was dealt a setback Tuesday when it learned the Food and Drug Administration did not approve its application for the bone graft device Augment,
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment
Isis Pharmaceuticals has found a new partner in Biogen Idec that’s betting a large amount of money on a new therapy for a rare spinal disorder in newborns. Weston, MA-based Biogen Idec (NASDAQ: BIIB)
Senators press Medtronic for device info
WASHINGTON - Three U.S. senators have asked Fridley-based Medtronic Inc. to supply detailed information about how the company keeps track of its medical devices after they go to
Baxter to acquire Synovis
Baxter International Inc. (NYSE:BAX) and Synovis Life Technologies, Inc. (NASDAQ:SYNO) today announced a definitive agreement for Baxter to acquire Synovis, a leading provider of biological and mechanical products
Update: Two ex-Synthes executives, Michael Huggins and Thomas Higgins, get 9 months in prison
UPDATE 3 p.m.: At about 2:45 p.m., Brent Gurney, the attorney for Richard Bohner, collapsed while standing at a lectern discussing his client with Judge Davis. Gurney was